The food-effect bioavailability study of Ro 31-7453 [R 440; MKC-1], a novel cell cycle inhibitor, in stable patient volunteers with solid tumors
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2010
At a glance
- Drugs MKC 1 (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 03 Feb 2010 Last checked against ClinicalTrials.gov record.
- 17 Dec 2009 Actual end date (Oct 2001) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.